Korea needs speedy mergers of several research centers among major drug makers

Large domestic pharmaceutical companies should focus on research and development (R&D) of new drugs in a form to create a new research center merging several research laboratories, according to pharmaceutical observers.

Observers say Korea can no longer depend on sales of generic drugs, adding that it is now vital for domestic companies to develop various technologies and advance into foreig...